Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada

被引:82
作者
De Azavedo, JCS
Yeung, RH
Bast, DJ
Duncan, CL
Borgia, SB
Low, DE
机构
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Princess Margaret Hosp, Dept Microbiol, Toronto, ON M4X 1K9, Canada
[3] Univ Toronto, MDS Labs, Toronto, ON, Canada
[4] Univ Toronto, Dept Pathobiol & Lab Med, Toronto, ON, Canada
关键词
D O I
10.1128/AAC.43.9.2144
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 3,205 group A streptoccal isolates were collected in 1997 through a private laboratory which serves community physicians in southern Ontario and which represents a population base of 6 million people. Nonsusceptibility to erythromycin was detected for 67 (2.1%) isolates both by disk diffusion and by broth microdilution. Of these, 47 (70%) were susceptible to clindamycin and were found by PCR to possess the mef gene. Of the other 20 strains, 18 and 2 showed inducible and constitutive resistance, respectively, to clindamycin. Nineteen of these strains were show by PCR to possess the ermTR gene, and a single constitutively resistant strain harbored an ermB gene. Sixteen (24%) erythromycin-resistant strains were also resistant to tetracycline, All were susceptible to penicillin and chloramphenicol.
引用
收藏
页码:2144 / 2147
页数:4
相关论文
共 29 条
  • [11] Why have group A streptococci remained susceptible to penicillin? Report on a symposium
    Horn, DL
    Zabriskie, JB
    Austrian, R
    Cleary, PP
    Ferretti, JJ
    Fischetti, VA
    Gotschlich, E
    Kaplan, EL
    McCarty, M
    Opal, SM
    Roberts, RB
    Tomasz, A
    Wachtfogel, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) : 1341 - 1345
  • [12] DECREASED ACTIVITY OF ERYTHROMYCIN AGAINST STREPTOCOCCUS-PYOGENES IN TAIWAN
    HSUEH, PR
    CHEN, HM
    HUANG, AH
    WU, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) : 2239 - 2242
  • [13] Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes
    Jasir, A
    Schalén, C
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) : 135 - 137
  • [14] Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
    Johnston, NJ
    De Azavedo, JC
    Kellner, JD
    Low, DE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2425 - 2426
  • [15] Erythromycin resistance genes in group A streptococci in Finland
    Kataja, J
    Huovinen, P
    Skurnik, M
    Seppälä, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 48 - 52
  • [16] Clonal spread of group A Streptococcus with the new type of erythromycin resistance
    Kataja, J
    Huovinen, P
    Muotiala, A
    Vuopio-Varkila, J
    Efstratiou, A
    Hallas, G
    Seppälä, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) : 786 - 789
  • [17] BACTERIAL-RESISTANCE TO MACROLIDE, LINCOSAMIDE, AND STREPTOGRAMIN ANTIBIOTICS BY TARGET MODIFICATION
    LECLERCQ, R
    COURVALIN, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) : 1267 - 1272
  • [18] Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes
    Lopardo, HA
    Venuta, ME
    Vidal, P
    Rosaenz, L
    Corthey, C
    Farinati, A
    Couto, E
    Sarachian, B
    Sparo, M
    Kaufman, S
    DeMier, CA
    Gubbay, L
    Scilingo, V
    Villaverde, P
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (01) : 29 - 32
  • [19] SENSITIVITY OF GROUP-A STREPTOCOCCI TO ANTIBIOTICS - PREVALENCE OF RESISTANCE TO ERYTHROMYCIN IN JAPAN
    MARUYAMA, S
    YOSHIOKA, H
    FUJITA, K
    TAKIMOTO, M
    SATAKE, Y
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1979, 133 (11): : 1143 - 1145
  • [20] COMPARISON OF GENOMIC DNAS OF DIFFERENT ENTEROCOCCAL ISOLATES USING RESTRICTION ENDONUCLEASES WITH INFREQUENT RECOGNITION SITES
    MURRAY, BE
    SINGH, KV
    HEATH, JD
    SHARMA, BR
    WEINSTOCK, GM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2059 - 2063